Clinical Trials
2 trialsNCT06911606 2025-04-04
Study of Serplulimab Plus Chemotherapy as Neoadjuvant Therapy for Limited-stage Small Cell Lung Cancer (LS-SCLC)
Guangdong Provincial People's Hospital
Phase 2 Recruiting
NCT06371482 2024-06-17
Durvalumab Combined With Chemoradiotherapy for Limited Stage Small Cell Lung Cancer (Camel-01)
Hebei Medical University Fourth Hospital
Phase 2 Recruiting